Skip to main content

1-20 of 2,721 results for subject:Finance

Department X
Department of Health
Subject X
Health authorities

Type

House

Session

Year

Department

Department of Health (2,721)
More

Member

More

Primary member

More

Answering member

More

Legislative stage

Legislation

More

Subject

More
Health authorities (2,721)

Publisher


Show detailed: On Off
Results: 10 20 50 100
Sort by: Newest first Oldest first

To ask the Secretary of State for Health, whether he plans to change the (a) role of, (b) responsibilities of and (c) funding allocated to strategic health authorities.

Asked by
Neil Carmichael (Conservative)
Answering body
Department of Health
Type
Written questions
Status
Answered
Date
14 April 2016
Reference
32778
House
House of Commons
Deposited by
Department of Health
Type
Deposited papers
Date
3 September 2012
Reference
DEP2012-1367
House
House of Commons
Deposited by
Department of Health
Type
Deposited papers
Date
11 June 2012
Reference
DEP2012-0907
House
House of Commons

To ask the Secretary of State for Health with reference to the answer of 30 April 2012, Official Report, column 1288W, on cancer, what funding earmarked for cancer networks was included in the Strategic Health Authority bundle for (a) 2009-10, (b) 2010-11 and (c) 2012-13.

[107823]

Asked by
Adrian Sanders (Liberal Democrat)
Answering body
Health
Type
Written questions
Status
Answered
Date
21 May 2012
Reference
107823; 545 cc458-9W
House
House of Commons
Deposited by
Department of Health
Type
Deposited papers
Date
12 March 2012
Reference
DEP2012-0460
House
House of Lords

My Lords, I support the amendment of my noble friend Lady Finlay of Llandaff. I noted what my noble friend Lady Murphy said. The Minister is aware that I have a long-standing concern about less-than-mainstream services for children and families, particularly in the mental health area. It became apparent several...

Member
Earl of Listowel (Crossbench)
Type
Proceeding contributions
Date
29 February 2012
Reference
735 c1321
House
House of Lords

My Lords, I support everything that the noble Lord, Lord Hunt, has said and declare an interest as vice-president of the British Fluoridation Society. I believe in the efficacy of the fluoride ion, and during my own dental career have seen the beneficial results of this public health measure. I...

Member
Lord Colwyn (Conservative)
Type
Proceeding contributions
Date
29 February 2012
Reference
735 c1362
House
House of Lords

Everything that needs to be said has been said; I thoroughly approve of this amendment and ask the Minister to note my support as a former dentist.

Member
Baroness Gardner of Parkes (Conservative)
Type
Proceeding contributions
Date
29 February 2012
Reference
735 c1362
House
House of Lords

The noble Baroness is not only disagreeing with the noble Baroness, Lady Finlay, and the noble Lord, Lord Walton, but disagreeing with all the organisations associated with these particular rare diseases. They think that the way forward is in the amendment of the noble Baroness, Lady Finlay.

Member
Lord Harris of Haringey (Labour)
Type
Proceeding contributions
Date
29 February 2012
Reference
735 c1319
House
House of Lords

I will respond briefly to that. We all have tremendous sympathy with the fact that very many rare conditions are not currently commissioned to the standard that we would wish. It is also true, by the way, that many ordinary conditions are not commissioned to the standard of service across...

Member
Baroness Murphy (Crossbench)
Type
Proceeding contributions
Date
29 February 2012
Reference
735 c1319-20
House
House of Lords

My Lords, I quake to disagree with my noble friends Lord Walton and Lady Finlay about Amendment 96 but I do so as someone who has been the chief executive of a very large health commissioning organisation. It is utterly crucial that rare conditions are considered individually and that the...

Member
Baroness Murphy (Crossbench)
Type
Proceeding contributions
Date
29 February 2012
Reference
735 c1319
House
House of Lords

79A: Clause 24, page 36, line 1, at end insert— ““14NA Registers of interests and management of conflicts of interest (1) Each clinical commissioning group must maintain one or more registers of the interests of— (a) the members of the group, (b) the members of its governing body, (c) the...

Member
Baroness Barker (Liberal Democrat)
Type
Proceeding contributions
Date
29 February 2012
Reference
735 c1334-5
House
House of Lords

82A: Schedule 2, page 281, leave out lines 32 to 34 Amendment 82A agreed. Amendments 83 and 84 had been withdrawn from the Marshalled List. Amendments 85 and 86 not moved. Amendments 86A and 86B Moved by

Member
Baroness Barker (Liberal Democrat)
Type
Proceeding contributions
Date
29 February 2012
Reference
735 c1335
House
House of Lords

86A: Schedule 2, page 281, line 38, at end insert— ““( ) The constitution must specify the arrangements made by the clinical commissioning group for discharging its duties under section 14NA(1) to (4).”” 86B: Schedule 2, page 282, leave out lines 33 to 34 Amendments 86A and 86B agreed. Amendments...

Member
Baroness Barker (Liberal Democrat)
Type
Proceeding contributions
Date
29 February 2012
Reference
735 c1335
House
House of Lords

92A: Schedule 2, page 288, line 12, at end insert— ““Seal and evidence (1) The application of a clinical commissioning group's seal must be authenticated by the signature of any person who has been authorised (generally or specially) for that purpose. (2) Any instrument which, if executed by an individual,...

Member
Earl Howe (Conservative)
Type
Proceeding contributions
Date
29 February 2012
Reference
735 c1335
House
House of Lords

On the first question from the noble Baroness, we fully anticipate that NICE will provide quality standards and guidance on services commissioned by CCGs and local authorities jointly. Typically, those are the kinds of service that the noble Baroness has spoken of, some of them in relation to less common...

Member
Earl Howe (Conservative)
Type
Proceeding contributions
Date
29 February 2012
Reference
735 c1329-30
House
House of Lords

In moving the amendment, I asked the Minister for an unqualified assurance that all people resident in England would be covered by a clinical commissioning group, and I have to say that I think he gave me that assurance. However, I simply ask that between now and Third Reading, if...

Member
Baroness Williams of Crosby (Liberal Democrat)
Type
Proceeding contributions
Date
29 February 2012
Reference
735 c1330
House
House of Lords

76: Clause 24, page 35, line 9, at end insert— ““( ) provide for the chair and non-executive members of each governing body to be appointed using an independent process, the details of which are to be laid out in regulations;””

Member
Lord Hunt of Kings Heath (Labour)
Type
Proceeding contributions
Date
29 February 2012
Reference
735 c1330
House
House of Lords

The Minister thought that I was projecting a doomsday view of corporate governance within clinical commissioning groups. It is not doomsday but a warning that if you give enormous power to professionals who can take advantage financially from their decisions, you need strong corporate governance safeguards. The best safeguard is...

Member
Lord Hunt of Kings Heath (Labour)
Type
Proceeding contributions
Date
29 February 2012
Reference
735 c1330
House
House of Lords

My Lords, if there is a common theme to these amendments, I suggest it might be the fear of falling through the cracks, and I hope I can demonstrate that there are no cracks to fall through. However, there is a lot to cover and I apologise in advance if...

Member
Earl Howe (Conservative)
Type
Proceeding contributions
Date
29 February 2012
Reference
735 c1324-9
House
House of Lords